Metabolic profiling of maternal serum of women a high-risk of spontaneous 
preterm birth using NMR and MGWAS approach

Gupta, Juhi K.; Care, Angharad; Goodfellow, Laura; Alfirevic, Zarko; Lian, Lu-Yun; Mueller-Myhsok, Bertram; Alfirevic, Ana; Phelan, Marie M.

doi:10.1042/BSR20210759

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Metabolic profiling of maternal serum of women a high-risk of spontaneous preterm birth using NMR and MGWAS approach

MPS-Authors

/persons/resource/persons80450

Mueller-Myhsok, Bertram
RG Statistical Genetics, Max Planck Institute of Psychiatry, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Gupta, J. K., Care, A., Goodfellow, L., Alfirevic, Z., Lian, L.-Y., Mueller-Myhsok, B., et al. (2021). Metabolic profiling of maternal serum of women a high-risk of spontaneous preterm birth using NMR and MGWAS approach. BIOSCIENCE REPORTS, 41(9): BSR20210759. doi:10.1042/BSR20210759.

Cite as: https://hdl.handle.net/21.11116/0000-0009-2CB7-8

Abstract

Preterm birth (PTB) is a leading global cause of infant mortality. Risk factors include genetics, lifestyle choices and infection. Understanding the mechanism of PTB could aid the development of novel approaches to prevent PTB. This study aimed to investigate the metabolic biomarkers of PTB in early pregnancy and the association of significant metabolites with participant genotypes. Maternal sera collected at 16 and 20 weeks of gestation, from women who previously experienced PTB (high-risk) and women who did not (low-risk controls), were analysed using H-1 nuclear magnetic resonance (NMR) metabolomics and genome-wide screening microarray. ANOVA and probabilistic neural network (PNN) modelling were performed on the spectral bins. Metabolomics genome-wide association (MGWAS) of the spectral bins and genotype data from the same participants was applied to determine potential metabolite-gene pathways. Phenylalanine, acetate and lactate metabolite differences between PTB cases and controls were obtained by ANOVA and PNN showed strong prediction at week 20 (AUC = 0.89). MGWAS identified several metabolite bins with strong genetic associations. Cis-eQTL analysis highlighted TRAF1 (involved in the inflammatory pathway) local to a non-coding SNP associated with lactate at week 20 of gestation. MGWAS of a well-defined cohort of participants highlighted a lactate-TRAF1 relationship that could potentially contribute to PTB.